Oppenheimer & CO Inc Personalis, Inc. Transaction History

Oppenheimer & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$20.71 - $51.02 $229,860 - $566,270	-11,099 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$21.84 - $44.0 $67,310 - $135,608	-3,082 Reduced 21.73%	11,099 $406,000
Q3 2020 Nov 13, 2020	SELL	$13.63 - $24.12 $28,459 - $50,362	-2,088 Reduced 12.83%	14,181 $307,000
Q2 2020 Aug 11, 2020	BUY	$7.65 - $14.11 $29,368 - $54,168	3,839 Added 30.88%	16,269 $211,000
Q1 2020 May 08, 2020	BUY	$4.75 - $12.41 $59,042 - $154,256	12,430 New	12,430 $100,000

112

30M

10.9K

87.8K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $149M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.